The Global Bio-imaging Market is Driven by Increasing Incidences of Chronic Diseases
The global bio-imaging market involves the use of various medical imaging technologies like X-Ray, MRI, ultrasound, nuclear imaging and so on for visual representation, characterization and analysis of biological processes taking place at the molecular, cellular and anatomical levels within living systems. These techniques help detect various abnormalities or diseases at an early stage for timely diagnosis and treatment options. Bio-imaging finds applications in drug discovery and development, biomarker discovery efforts, molecular and cellular mapping studies. The versatility of these techniques allow researchers and clinicians to obtain both morphological as well as functional information non-invasively.
The Global Bio-imaging Market is estimated to be valued at US$ 5.74 Bn in 2024 and is expected to exhibit a CAGR of 15.% over the forecast period 2024 to 2031.
Key players operating in the Global Bio-imaging Market Demand are Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc., Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc., Samsung Medison Co., Ltd., and Philips Healthcare.
Key Takeaways
Key players operating in the global bio-imaging market are Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc., Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc., Samsung Medison Co., Ltd., and Philips Healthcare. These players are focusing on new product launches, partnerships and mergers to gain a competitive advantage in the market.
Growing demand in market
The growing incidences of chronic diseases like cancer, cardiovascular diseases etc and the need for early and accurate diagnosis is the major factor driving the demand for global bio-imaging market. Moreover, growing geriatric population who are more prone to developing such conditions is further propelling the market growth.
Global expansion of market
Key players in the global bio-imaging market are expanding their geographical presence by strengthening their distribution networks across major markets. They are also investing heavily in R&D to develop newer and advanced bio-imaging technologies and solutions. This is broadening the scope of applications as well as driving the adoption of these systems worldwide.
Get more insights on Global Bio-imaging Market
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian